June 20, 2026 a 01:00 pm
DXCM: Fundamental Ratio Analysis - DexCom, Inc.
DexCom, Inc. operates within the healthcare sector, concentrating on continuous glucose monitoring systems crucial for diabetic management. Its innovative approach, coupled with strong collaborations, positions it solidly in the medical technology landscape. With a focus on globally expanding its offerings, the stock represents a robust player in a niche market.
Fundamental Rating
DexCom, Inc.'s fundamentals reflect a solid performance in key areas, yet suggest room for growth regarding valuation metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Analyzing historical ratings provides insight into DexCom, Inc.'s incremental improvements and areas needing attention.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | 3 | 4 | 5 | 5 | 2 | 2 | 1 |
| Previous | 0 | 4 | 5 | 5 | 2 | 2 | 1 |
Analyst Price Targets
Analysts provide optimistic estimates for DexCom, Inc., indicating potential for appreciation. However, some diversification in opinion is present.
| High | Low | Median | Consensus |
|---|---|---|---|
| $95 | $64 | $85 | $83.56 |
Analyst Sentiment
The sentiment shows an overall positive outlook, with a significant number of buy recommendations signaling bullish prospects.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 41 | |
| Hold | 8 | |
| Sell | 2 | |
| Strong Sell | 0 |
Conclusion
DexCom, Inc. stands as a pivotal player in the medical technology sector, with its focus on CGM systems offering substantial growth avenues. Its strong ratings in ROE and ROA showcase efficient management, though valuation models such as DCF and P/E suggest cautious optimism. Analyst sentiment is predominantly positive, bolstering investor confidence despite the moderate risks. Continued product innovation and international market expansion could further solidify its market stance.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years